They look cute, familiar or downright boring, yet these creatures quietly help drive a national injury toll that sends ...

EURneffy 1 mg will be the first and only needle-free adrenaline available to younger children in the European UnionARS Pharma’s partner, ...

EURneffy 1 mg will be the first and only needle-free adrenaline available to younger children in the European Union ...

Deficiencies limited to packaging and administrationCompany believes it can rapidly resolve deficiencies and expects to resubmit as early as Q3 2026Remains well-capitalized and anticipates ending 2026 ...

Aquestive Therapeutics said on Monday the U.S. FDA has declined to approve its oral drug for severe allergic reactions due to packaging issues, marking a setback to its efforts to enter the allergy ...

The code injection flaws allow for unauthenticated remote code execution on Ivanti Endpoint Manager Mobile deployments, but ...

The Custom Assistant Shortcut in Android Auto lets you set up complex actions and routines that can be activated with a single button press.

Parents and carers urged to refresh first aid knowledge as Australian students return to school, particularly regarding allergies and ...

Using same proprietary, patented technology, VIVI Med extends the product portfolio beyond injectable pens, opening access to broader patient populations, premium ...

Health care isn’t a luxury. It’s foundational. It determines whether people can work, raise healthy families, and stay rooted ...

An education module for internal medicine residents improves counseling of patients with food allergies on the use of ...

California joins 23 other states eligible to receive free neffy ® (epinephrine nasal spray) at schools. SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Na ...